Wheeling, IL, United States of America

Nancy L Fregeau Gallagher


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nancy L Fregeau Gallagher: Innovator in Antitumor Compounds

Introduction

Nancy L Fregeau Gallagher is a notable inventor based in Wheeling, IL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor compounds. With a total of two patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Gallagher's latest patents include compositions and methods comprising long-chain, straight-chain 2-amino-3-hydroxyalkanes. This invention focuses on the activity of extracts from clams, which have led to the discovery of antitumor compounds featuring a 2-amino group and a 3-hydroxy group. The patent details the use of isolated and purified long-chain, straight-chain 2-amino-3-hydroxyalkanes, or prodrugs thereof, combined with a pharmaceutically acceptable carrier. Another significant patent involves Spisulosine compounds, which also stem from the investigation of clam extracts and their antitumor properties.

Career Highlights

Throughout her career, Gallagher has worked with various institutions, including the University of Illinois. Her research has focused on innovative methods to combat cancer through the use of natural compounds derived from marine life.

Collaborations

Some of her notable collaborators include Kenneth L Rinehart and Robert A Warwick. Their combined expertise has contributed to the advancement of her research and the successful development of her patents.

Conclusion

Nancy L Fregeau Gallagher's work in the field of antitumor compounds showcases her innovative spirit and dedication to scientific research. Her contributions continue to impact the pharmaceutical industry and offer hope for new cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…